Preventing Hepatitis C in Prisons: The Role of Opioid Agonist Treatment (OAT)

Posted Saturday 07 June 2025 | ASHM Health

ASHM, in collaboration with the National Prisons Hepatitis Network, invites you to a free national Lunch and Learn webinar exploring the critical role of Opioid Agonist Treatment (OAT) in preventing hepatitis C (HCV) in correctional settings. Delivered by experts from across the country, the session features insights from the authors of the National Consensus Statement on OAT in custodial settings, alongside real-world experiences from New South Wales and Queensland correctional programs.

Designed for healthcare professionals, peer workers, policymakers, and anyone working to improve health in correctional settings.

Find out more by clicking the registration button or by visiting the ASHM website.

Click here to download the flyer for this event.

Learning outcomes

To explore best practice recommendations for OAT implementation in prisons in the context of hepatitis C prevention.

By the end of this webinar, participants will be able to:

• Describe the role of OAT as a key enabler for hepatitis C prevention in custodial settings.
• Explore opportunities to expand and sustain OAT delivery through real-world implementation strategies.
• Highlight successful models of OAT integration and practical insights from prison-based programs.

Endorsement and CPD

RACGP: Pending accreditation with RACGP. ASHM is an RACGP-accredited CPD Provider under the RACGP CPD Program. 

Funding

This event is supported by an unconditional education grant from Gilead Sciences. Sponsorship is provided in accordance with the ASHM’s Sponsorship Policy. ASHM does not endorse or promote any sponsor’s product or service.